EGOT and breast cancer: Nine lncRNAs associated with m7G (LINC01871, AP003469.4, Z68871.1, AC245297.3, EGOT, TFAP2A-AS1, AL136531.1, SEMA3B-AS1, AL606834.2) could be employed as a predictive signature in patients with BC, according to multivariate Cox regression and Lasso regression analysis (Figures 2A–C).